$1.66 Billion in Sales Expected for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) This Quarter

Retrieved on: 2021-07-06 06:11:15

Tags for this article:

Life Sciences

Biotechnology

Health care

Specialty drugs

Alexion Pharmaceuticals

AstraZeneca

Pharmaceuticals policy

Eculizumab

Pharmaceutical industry in China

David L. Hallal

Alexion Pharmaceuticals Inc.

Zacks Investment Research

Click the tags to see associated articles and topics

$1.66 Billion in Sales Expected for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) This Quarter. View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-alxn-consensus-analyst-rating-2021-07/

Excerpt

Equities research analysts expect that Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) will report sales of $1.66 billion for the current quarter, Zacks ...

Article found on: www.marketbeat.com

View Original Article